among contacts living in areas where tuberculosis was widespread and patients were
usually not segregated. In the Saskatchewan trial 68.7% of the controls became infected at …

To the editor: Dr. Narain's editorial (Can Med Assoc J 1982; 127: 101-102) on the need for a
BCG (bacille Calmette-Gu. rin) trial in Canada's native populations is timely and deserves …

THE DECISION to use, or to stop using, a method of immunization or vaccination depends
on several factors; theseinclude the epidemiological situation in the community concerned …

As a result of BCG vaccination trials carried out by the United States Public Health Service in
Puerto Rico, Georgia and Alabama it was concluded that tuberculosis in the vaccinated …

This paper reports a case-control study to assess the protective effect of BCG (bacille
Calmette-Guérin) vaccination among Indian infants in Manitoba, Canada. A record of past …

In spite of a growing enthusiasm for BCG, its use remained limited in some countries,
including the United States and Great Britain, reflecting the judgment that convincing …

EXTRINSIC FACTORS IN THE EVALUATION OF BCG Alberto Asooli, MD* Former Director
of the IVA,* New York, NY ONE would expect experimentation on lower animals always to …

Into this short article the authors have packed further convincing evidence of the value of
BCG vaccination in young children. The object was to determine the results of BCG …

This study was made jointly by the Tuberculosis Research Unit of the South African Medical
Research Council and the Health Department of Pretoria. It was prompted by the finding of …

The scheme for BCG vaccination at about age 13 years in England and Wales was
introduced in 1953. The coverage of the scheme is now 75%, and the efficacy of BCG has …